This inventor holds 2 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Valo Therapeutics Oy. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Erkko Ylösmäki: Innovator in Cancer Therapy
Introduction
Erkko Ylösmäki is a prominent inventor based in Helsinki, Finland. He has made significant contributions to the field of cancer therapy through his innovative work. His dedication to advancing medical science is evident in his patented invention.
Latest Patents
Erkko Ylösmäki holds a patent for a modified oncolytic adenovirus. This invention includes a pharmaceutical composition comprising the modified virus and a method for treating cancer using this innovative approach. His work represents a promising advancement in cancer treatment.
Career Highlights
Erkko is associated with Valo Therapeutics Oy, a company focused on developing novel therapies for cancer. His role in the company has allowed him to contribute to groundbreaking research and development in the field of oncology.
Collaborations
He collaborates with talented individuals such as Tuuli Ranki and Sari Pesonen. Their combined expertise enhances the innovative environment at Valo Therapeutics Oy.
Conclusion
Erkko Ylösmäki's contributions to cancer therapy through his patented invention highlight his commitment to improving patient outcomes. His work continues to inspire advancements in medical research and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile